CME
CME Group Inc
CME Group Inc historical holders
total: 11
Sanders Capital CME Group Inc transactions over time
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2025 Q3
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q2
Lewis Sanders has been an institutional investor in CME Group Inc (CME) since 2025 Q3. According to 2026 Q2 report, Lewis Sanders holds 5,067,740 shares with a market value of roughly $1.12B representing 1.12% of their equity portfolio. The fund/company first acquired CME in 2025 Q3, initially purchasing about 3.73M shares. Since the initial investment, Sanders Capital has made 3 more transactions in this position.
Does Lewis Sanders still hold CME?
Yes, Lewis Sanders continues to hold CME Group Inc (CME). According to their 2026 Q2 report, they maintain a position of 5,067,740 shares valued at approximately $1.12B, representing 1.12% of their equity portfolio.
When did Lewis Sanders first invest in CME?
Lewis Sanders first invested in CME Group Inc (CME) in 2025 Q3 at the reported quarter-end price of $270.19 per share, acquiring 3,726,755 shares in their initial purchase.
What is Lewis Sanders's average cost basis for CME?
Based on historical transaction data, Lewis Sanders's estimated cost basis for CME Group Inc (CME) is approximately $261.65 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $261.64
- Weighted AVG sell price:
- $295.35
CME transactions history by Sanders Capital
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.12%
|
5,067,740
|
$220.83
|
$1,119,109,024
|
+21.79% (+906,550)
|
+0.2%
|
|
2026 Q1
|
1.46%
|
4,161,190
|
$295.35
|
$1,229,007,467
|
-0.39% (-16,325)
|
-0.01%
|
|
2025 Q4
|
1.31%
|
4,177,515
|
$273.08
|
$1,140,795,796
|
+12.10% (+450,760)
|
+0.14%
|
|
2025 Q3
|
1.24%
|
3,726,755
|
$270.19
|
$1,006,931,933
|
new
|
+1.24%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.